Technology combining genetic engineering of cells with chemical engineering to create artificial organs and tissues such as skin , bone , heart valves , and cartilage for joints 结合细胞遗传工程和化学工程以创造器官和组织如：皮肤、骨头、心脏瓣膜和软骨关节的技术。
To investigate the aetiologies and characteristics of valve disorders and effects on cardiac structure and function in patients with chronic renal failure ( crf ) on maintenance hemodialysis 目的:探讨慢性肾功能衰竭维持性血液透析患者心脏瓣膜病变的性质、病因及对心脏结构和功能的影响。
Conclusions : to lower the morbidity and mortality , different kinds of nursing care should be applied to different cardiomegaly after heart valve replacement operations 结论：巨大心脏瓣膜置换术后应针对分型特点进行不同的监护，预防为主，减少盲目性，达到术后减少并发症和降低病死率，促进患者康复的目的。
Methods : retrospective analysis the clinic materials from 152 patients who have been done heart valve replacement and 11 patients complicated mental disorder in january 2004 to august 2006 in the hospital 方法：对我院2004 . 1 ~ 2006 . 8共行心脏瓣膜置换152例，术后并发精神异常11例的临床资料进行回顾性的分析。
The thesis is about the design and manufacture of a new type of artificial heart valve . it can be divided into three main parts : construction of the artificial heart valve design , manufacture and assembly process 本论文的内容是关于一种新型的双叶人工心脏瓣膜的设计与制造，可划分为三个主要部分：人工心瓣的结构设计，制造及装配工艺。
In 2003 , fda asked lilly to add alulopathy ( abnormality of cardiac ales ) to the warnings section of permax labeling , at which time a dear healthcare practitioner letter was sent by lilly 首次关于培高利特与瓣膜性心脏疾病相关的报道是在2002年， 2003年fda要求伊莱利利公司在培高利特标签的警告部分添加心脏瓣膜疾病的警示语，同时该公司发出了“致健康从业者信” 。
The product drawings and processes are tested . the good of the thesis is reached . the thesis form an excellent base of the series design , production and research of the artificial heart valve 完成的心脏瓣膜产品图纸、工艺和工艺装备，经试制过程考核验证，是正确的和可行的，达到了论文工作的预期目标，所作的探索，为人工心瓣的系列化设计，批量生产以及进一步研究奠定了良好的基础。
Results of 31 case patients with newly diagnosed cardiac - valve regurgitation , 6 were currently exposed to pergolide , 6 were currently exposed to cabergoline , and 19 had not been exposed to any dopamine agonist within the previous year 结果：有31例患者出现新诊断的心脏瓣膜返流，其中6例研究时正在服用培高利特， 6例使用卡麦角林，另外19例在研究的前一年中未再使用任何多巴胺受体激动剂。
This thesis is about the design and engineering analysis of a new type of bileaflet artificial heart valve . it can be divided into three main parts : theoretical calculation of the valve , computer aided design , engineering analysis 本论文的内容是关于一种新型的双叶型人工心脏瓣膜的设计与工程分析，可以划分为三个主要部分：人工心瓣的结构理论计算、计算机辅助设计以及计算机辅助工程分析。
Background case reports and echocardiographic studies suggest that the ergot - derived dopamine agonists pergolide and cabergoline , used in the treatment of parkinson ' s disease and the restless legs syndrome , may increase the risk of cardiac - valve regurgitation 背景：病例报告和超声心动图研究提示，用于治疗帕金森病和不宁腿综合征的药物?麦角?生物，多巴胺受体激动剂培高利特和卡麦角林，可能增加发生心脏瓣膜返流的风险。
